These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35803214)

  • 21. EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.
    Möller E; Praz V; Rajendran S; Dong R; Cauderay A; Xing YH; Lee L; Fusco C; Broye LC; Cironi L; Iyer S; Rengarajan S; Awad ME; Naigles B; Letovanec I; Ormas N; Finzi G; La Rosa S; Sessa F; Chebib I; Petur Nielsen G; Digklia A; Spentzos D; Cote GM; Choy E; Aryee M; Stamenkovic I; Boulay G; Rivera MN; Riggi N
    Nat Commun; 2022 Apr; 13(1):2267. PubMed ID: 35477713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel PTPRZ1-ETV1 fusion in gliomas.
    Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
    Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAD disruption as oncogenic driver.
    Valton AL; Dekker J
    Curr Opin Genet Dev; 2016 Feb; 36():34-40. PubMed ID: 27111891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factors in human leukaemias.
    Cleary ML
    Cancer Surv; 1992; 15():89-104. PubMed ID: 1451116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAX3-FOXO1: Zooming in on an "undruggable" target.
    Wachtel M; Schäfer BW
    Semin Cancer Biol; 2018 Jun; 50():115-123. PubMed ID: 29146205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How can oncogenic transcription factors cause cancer: a critical review of the myb story.
    Introna M; Golay J
    Leukemia; 1999 Sep; 13(9):1301-6. PubMed ID: 10482978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1.
    Sanchez-Prieto R; de Alava E; Palomino T; Guinea J; Fernandez V; Cebrian S; LLeonart M; Cabello P; Martin P; San Roman C; Bornstein R; Pardo J; Martinez A; Diaz-Espada F; Barrios Y; Ramon y Cajal S
    Nat Med; 1999 Sep; 5(9):1076-9. PubMed ID: 10470089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
    Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
    Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
    Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
    Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
    Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation-associated fusion cancer genes in solid tumors.
    Kaye FJ
    Mol Cancer Ther; 2009 Jun; 8(6):1399-408. PubMed ID: 19509239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatin modulation by oncogenic transcription factors: new complexity, new therapeutic targets.
    Hormaeche I; Licht JD
    Cancer Cell; 2007 Jun; 11(6):475-8. PubMed ID: 17560329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. REToma: a cancer subtype with a shared driver oncogene.
    Kohno T; Tabata J; Nakaoku T
    Carcinogenesis; 2020 Apr; 41(2):123-129. PubMed ID: 31711124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SWI/SNF complex in cancer - biology, biomarkers and therapy.
    Mittal P; Roberts CWM
    Nat Rev Clin Oncol; 2020 Jul; 17(7):435-448. PubMed ID: 32303701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.
    Ron D
    Curr Top Microbiol Immunol; 1997; 220():131-42. PubMed ID: 9103679
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of oncogenes in hematologic malignancies.
    Boxer LM
    Annu Rev Med; 1994; 45():1-11. PubMed ID: 8198369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Expression of Proto-Oncogene
    Khosh Kish E; Choudhry M; Gamallat Y; Buharideen SM; D D; Bismar TA
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion oncogenes in tumor development.
    Aman P
    Semin Cancer Biol; 2005 Jun; 15(3):236-43. PubMed ID: 15826838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.
    Werner H; Meisel-Sharon S; Bruchim I
    Mol Cancer; 2018 Feb; 17(1):28. PubMed ID: 29455671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.